Neogenomics

NEO NASDAQ
21.25
+0.13
+0.62%
After Hours: 21.25 0 0.00% 16:41 05/24 EDT
Open
21.24
Prev Close
21.12
High
21.67
Low
21.11
Volume
977.21K
Avg Vol (3M)
900.57K
52 Week High
23.85
52 Week Low
11.05
% Turnover
1.02%
Market Cap
2.03B
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Company Profile

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Houston, Texas and Nashville, and Tennessee. It offers testing services, which include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Immunohistochemistry (IHC), Molecular testing and Pathology consultation. Its Pharma Services and Clinical Trials group provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.
MORE >

Recently

Name
Price
%Change